RNF19A and neoplasm: Overexpression of RNF19A slightly promoted cancer cell growth without drug intervention while mice bearing RNF19A overexpressing MDA-MB-231 cells displayed more noticeable tumor shrinkage in the Olaparib treatment group (Fig. 6c–e).